SEC Filing Details
Document Details
Form
Filing Date
Aug 6, 2020
Document Date
Jun 30, 2020
Form Description
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Group
Current Reports
Company
BioLineRx
Issuer
BioLineRx Ltd.
XBRL
Press Releases View all
March 22, 2023
BioLineRx Reports 2022 Financial Results and Recent Corporate and Portfolio Updates
March 15, 2023
BioLineRx to Report 2022 Annual Financial Results on March 22, 2023